Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review
Olivia A. C. Lamers, Bas M. Smits, Helen L. Leavis, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Common Variable Immunodeficiency Associated With Noninfectious Pulmonary Complications and Its Treatment: Beyond Immunoglobulin Therapy
Austin Parsons, Domingo Franco‐Palacios, Bryan Kelly, et al.
Pulmonary Circulation (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives
Børre Fevang
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 6, pp. 627-638
Open Access | Times Cited: 15
Granulomatous inflammation in inborn errors of immunity
Keith Sacco, Andrea Gazzin, Luigi D. Notarangelo, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 14
Navigating the Complexities of Common Variable Immunodeficiency Enteropathy
Joud Hajjar, Atiq Ur Rehman, Ahmed Hamdi, et al.
Immunology and Allergy Clinics of North America (2025)
Closed Access
Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience
Luciano Urdinez, Lorenzo Erra, Alejandro Palma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients
Giulio Tessarin, Manuela Baronio, Luisa Gazzurelli, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 8, pp. 2091-2103
Open Access | Times Cited: 9
Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative Review
Helena Buso, Claudia Discardi, Patrick Bez, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1503-1503
Open Access | Times Cited: 3
Immunodeficiency: Burden of Illness
Justin C. Hsueh, Andrew T. Van Hersh, Wei Zhao
Allergy and Asthma Proceedings (2024) Vol. 45, Iss. 5, pp. 294-298
Closed Access | Times Cited: 3
Granulomas in Common Variable Immunodeficiency Display Different Histopathological Features Compared to Other Granulomatous Diseases
Astrid C. van Stigt, Jan H. von der Thüsen, Dana A. M. Mustafa, et al.
Journal of Clinical Immunology (2024) Vol. 45, Iss. 1
Open Access | Times Cited: 3
Integrating Clinics, Laboratory, and Imaging for the Diagnosis of Common Variable Immunodeficiency-Related Granulomatous–Lymphocytic Interstitial Lung Disease
Marta Dafne Cabañero-Navalón, Víctor García-Bustos, Leonardo Fabio Forero-Naranjo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease
Bas M. Smits, Sigune Goldacker, Suranjith L. Seneviratne, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 152, Iss. 2, pp. 528-537
Closed Access | Times Cited: 14
Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease
Jessica Galant-Swafford, Jason Catanzaro, Rosane Duarte Achcar, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102749-102749
Open Access | Times Cited: 2
Immunodysregulation in immunodeficiency
Christopher Chang
Allergy and Asthma Proceedings (2024) Vol. 45, Iss. 5, pp. 340-346
Closed Access | Times Cited: 2
STAT expression and TFH1 cells in CVID granulomatosis and sarcoidosis: immunological and histopathological comparisons
Jean‐François Viallard, Maëlig Lescure, Éric Oksenhendler, et al.
Virchows Archiv (2023) Vol. 484, Iss. 3, pp. 481-490
Closed Access | Times Cited: 5
Managing Granulomatous–Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey
Annick A. J. M. van de Ven, Tiago M. Alfaro, Alexandra Robinson, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 13
Common and Uncommon CT Findings in CVID-Related GL-ILD: Correlations with Clinical Parameters, Therapeutic Decisions and Potential Implications in the Differential Diagnosis
Riccardo Scarpa, Francesco Cinetto, Cinzia Milito, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 8, pp. 1903-1915
Open Access | Times Cited: 4
Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency
Bas M. Smits, Sharisa L. Boland, Marjolein E Hol, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 1037-1048.e3
Open Access | Times Cited: 1
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency
Astrid C. van Stigt, Giulia Gualtiero, Francesco Cinetto, et al.
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 6, pp. 479-487
Closed Access | Times Cited: 1
Take a Leap of Faith: Implement Routine Genetic Testing in Your Office
Kathryn D. Convers, Maria A. Slack, Henry J. Kanarek
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 7, pp. 1676-1687
Closed Access | Times Cited: 6
Corticosteroid-induced remission and mycophenolate maintenance therapy in granulomatous lymphocytic interstitial lung disease: long-term, longitudinal change in lung function in a single-centre cohort
Heba M Bintalib, David M. Lowe, Gaia Mancuso, et al.
ERJ Open Research (2022) Vol. 8, Iss. 4, pp. 00024-2022
Open Access | Times Cited: 5
Granulomatous–lymphocytic interstitial lung disease: an international research prioritisation
John R. Hurst, S. Abbas, Heba M Bintalib, et al.
ERJ Open Research (2021) Vol. 7, Iss. 4, pp. 00467-2021
Open Access | Times Cited: 7
Allogeneic Hematopoietic Cell Transplantation Ameliorated Asymptomatic Granulomatous and Lymphocytic Interstitial Lung Disease in a Patient With XIAP Deficiency
Mai Oshima, Yukihiro Matsukawa, Yuhachi Ikeda, et al.
Journal of Pediatric Hematology/Oncology (2024) Vol. 46, Iss. 2, pp. e191-e194
Closed Access
Granulomas in common variable immunodeficiency display different histopathological features compared to other granulomatous diseases
Astrid C. van Stigt, Jan H. von der Thüsen, Dana A. M. Mustafa, et al.
Research Square (Research Square) (2024)
Open Access
Case 20-2024: A 73-Year-Old Man with Recurrent Fever and Liver Lesions
Lakshmi Ganapathi, Rory L. Cochran, Gregory K. Robbins, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 24, pp. 2309-2319
Closed Access
Glimpses into treating GLILD
Timi Martelius, Mikko Seppänen
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 2, pp. 365-367
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top